Moneycontrol PRO
you are here: HomeNewsIndia
Live now
auto refresh
December 09, 2021 / 10:57 PM IST

Coronavirus Omicron India Highlights: FDA expands Pfizer COVID-19 booster shots to age 16 amid new variant scare

Coronavirus Omicron India Highlights: With the emergence of the new COVID-19 Omicron variant, the Karnataka government has issued guidelines of dedicated isolation, treatment and management facility for Omicron cases.

Coronavirus Omicron India Highlights: Mumbai airport is working with testing labs and other partners to further reduce the charges for rapid RT-PCR test. Even though the charges have been revised recently, they are still too high, the state told the Centre recently. With the emergence of the new COVID-19 Omicron variant, the Karnataka government has issued guidelines of dedicated isolation,
treatment and management facility for Omicron cases. Even as Maharashtra reports 10 Omicron Covid variant cases, Maharashtra Health Minister Rajesh Tope on Wednesday assured that there is no need to panic as severity of the new strain is low. Further, ruling out possibilities of Covid-restrictions as of now, Tope said, earlier this week, such measures will be taken only after seeking the Centre's guidance and Chief Minister Uddhav Thackeray's views. Maharashtra's first patient of the Omicron covid variant was on Wednesday discharged from a hospital after testing negative for the infection. He had been admitted to a COVID Care Centre in Kalyan town.
  • December 09, 2021 / 10:56 PM IST

    Coronavirus Omicron India LIVE Updates | Travel bans imposed by the EU, Britain, and the United States because of the Omicron coronavirus variant have cut off South Africa's tourism industry from its three biggest markets and dashed all hopes of a revival this holiday season.

  • December 09, 2021 / 10:41 PM IST

    Coronavirus Omicron India LIVE Updates | Both reports of all the nine Omicron positive patients admitted in RUHS Hospital, Jaipur comes negative. All discharged from hospital, advised to remain in home quarantine for seven days: Rajasthan Health Department

  • December 09, 2021 / 10:21 PM IST

    Coronavirus Omicron India LIVE Updates | UK's Omicron variant cases nearly double in a day   

    The number of cases of the Omicron variant of COVID-19 in Britain has nearly doubled in one day after a further 249 cases were confirmed on Thursday, bringing the UK total to 817. The UK Health Security Agency (UKHSA) said if the growth rate and doubling time continue at the rate seen in the last two weeks, they expect to see at least 50 percent of coronavirus (COVID-19) cases to be caused by Omicron variant in the next two to four weeks.

  • December 09, 2021 / 10:00 PM IST

    Coronavirus Omicron India LIVE Updates | FDA expands Pfizer COVID-19 booster shots to age 16 amid new variant scare

    The US is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizers vaccine.

    The US and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccination, calls that intensified with the discovery of the worrisome new omicron variant.

  • December 09, 2021 / 09:44 PM IST

    Coronavirus Omicron India LIVE Updates | Omicron cases so far appear ‘mostly mild’: EU agency

  • December 09, 2021 / 09:23 PM IST

    Coronavirus India LIVE Updates | Gujarat reports 70 new COVID-19 cases, 0 deaths, 28 recoveries in last 24 hours

    Total cases 8,27,943

    Total recoveries 8,17,389

    Death toll 10,095

    Active 459

  • December 09, 2021 / 08:49 PM IST

    Coronavirus Omicron India LIVE Updates | Mumbai COVID-19 genome sequencing: Only 2 of 211 samples were Omicron      

    The Mumbai civic body on Thursday said the genome sequencing of 211 COVID-19 samples showed that two of them had the newer Omicron variant, while some 89 percent had the Delta derivative and 11 percent the Delta variant. This was the fifth batch of samples sent for genome sequencing, and none of the patients from whom the samples were collected was deceased, a Brihanmumbai Municipal Corporation release said.

  • December 09, 2021 / 08:17 PM IST

    Coronavirus Omicron India LIVE Updates | SEC meet on vaccine booster shots tomorrow

    The Subject Expert Committee (SEC) on COVID-19 will hold a meeting on December 10 on coronavirus vaccine booster doses. Recently, the Serum Institute of India has sought approval from DCGI for Covishield as a booster dose citing its adequate stock in the country and demand for booster shot due to the emergence of the new variant.

  • December 09, 2021 / 07:53 PM IST

    Coronavirus Omicron India LIVE Updates: Dr Reddy's Laboratories seeks DCGI's nod for phase-3 trial of Sputnik Light as booster dose 

    Dr Reddy's Laboratories has sought permission from India's drug regulator to conduct a phase-3 clinical trial to evaluate the efficacy and safety of Sputnik Light vaccine as a booster dose against COVID-19 in India, sources said on Thursday. Stating the Sputnik Light is the Component 1 of the Gam-COVID-Vac Combined Vector Vaccine (Sputnik V), P Madhavi, the Director-Regulatory Affairs at Dr Reddy's Laboratories, proposed to use batches of the vaccine manufactured at Hetero Biopharma Limited, Telangana, and at its loan license facility at Shilpa Biologicals Private Limited in Karnataka for the phase-3 trial. Sputnik Light has not yet received emergency use authorisation from the Drugs Controller General of India (DCGI). "Seeking your permission to conduct 'a phase-3 randomized, open-label three-arm, multi-centre, clinical study in parallel assignment to evaluate immunogenicity and safety of a booster dose of Sputnik Light vector vaccine against COVID-19 in healthy Indian subjects," a source quoted Madhavi as having said in the application.

  • December 09, 2021 / 07:35 PM IST

    Coronavirus Omicron India LIVE Updates: AstraZeneca in touch with Indian authorities for approval to COVID drug 

    Biopharmaceutical multinational AstraZeneca on Thursday said it has initiated engagements with Indian health authorities to provide the latest evidence of Evusheld, its COVID-19 prevention drug for people with weakened immune system which has received emergency use authorisation (EUA) in the US. The long acting antibody combination has been granted the EUA in the US for COVID-19 prevention in adults and adolescents (above 12 years and weighing 40kg or more) with moderate to severely weakened immune system who may not have an adequate immune response to COVID-19 vaccination, as well as those individuals for whom COVID-19 vaccination is not recommended, the company said. "We welcome this news and the opportunity it provides to support the unmet needs of high risk and immune-compromised patients and we have already initiated engagements with the relevant health authorities in India to provide them with the latest evidence," AstraZeneca India Pharma Ltd Managing Director Gagandeep Singh Bedi said in a statement. (PTI)

  • December 09, 2021 / 07:20 PM IST

    Coronavirus Omicron India LIVE Updates: EU countries expected to agree 9-month duration of COVID pass: Report

    European Union countries are expected to agree to limit to nine months the duration of COVID-19 certificates for travel, two EU sources told Reuters, as talks continue about restrictions for inbound travellers from outside the bloc. The EU executive commission proposed in November a nine-month validity limit for COVID-19 passes from the completion of the primary vaccine doses. If applied, EU citizens wanting to travel freely next summer across the bloc would need a booster shot. One EU official and one EU diplomat said EU governments were expected to reach a consensus on the nine-month limit as early as Friday after a preliminary agreement on Thursday, although one said talks could stretch into next week. A third diplomat said there was general support for the nine-month limit, but some countries with lower vaccination rates were concerned about the impact this could have on travel. EU governments have repeatedly said a common approach is needed to avoid further disruption for the travel industry. However, they have introduced diverging rules. France set a seven-month limit on the day the Commission proposed it should be nine months. The French rule is to apply from Januaty 15, whereas the Commission has proposed a January 10 start.

  • December 09, 2021 / 07:03 PM IST

    Coronavirus Omicron India LIVE Updates: WHO fears Omicron could spur fresh vaccine hoarding 

    The World Health Organization said Thursday it remained unclear whether additional Covid-19 vaccine doses are needed to protect against the new Omicron variant, and urged wealthy countries to avoid hoarding the jabs. The UN health agency's vaccine advisors warned that a rush to stockpile more jabs, especially without clear evidence they are needed, would only exacerbate the already glaringly inequal vaccine access around the globe. "As we head into whatever the Omicron situation is going to be, there is a risk that the global supply is again going to revert to high-income countries hoarding vaccine to protect (their populations) ... in a sense in excess," WHO vaccines chief Kate O'Brien told reporters.

ISO 27001 - BSI Assurance Mark